Inve US ▾
GNGNW

Genworth Financial (GNW) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Financials· May 6, 2026

Source: earnings call transcript

Executive summary

Genworth Financial Q1 FY26 — Strong ANAC Performance Fuels Capital Returns and CareScout Growth

Genworth Financial reported strong Q1 FY26 results driven by ANAC's performance, which continues to fund capital returns and strategic investments in CareScout. The company is refining its reporting to exclude the Closed Block's GAAP volatility, emphasizing its self-sustaining nature while focusing on long-term growth opportunities through CareScout's expanding network and product offerings. Management remains committed to disciplined capital allocation and liability management amidst a dynamic macroeconomic environment.

Highlights

5

  • Adjusted operating income, excluding the closed block, was $109 million in Q1 FY26.

  • ANAC delivered strong performance with adjusted operating income of $140 million to Genworth.

  • Received $99 million in total capital returns from ANAC in Q1 FY26.

  • Repurchased $66 million of shares at an average price of $8.61 per share in Q1 FY26, with an additional $19 million through April 30.

  • CareScout facilitated approximately 1,500 matches in Q1 FY26, reflecting strong sequential and year-over-year growth.

Concerns

4

  • Closed Block segment reported an adjusted operating loss of $32 million in Q1 FY26.

  • Closed Block AE losses are expected to be approximately $300 million for the full year 2026.

  • Corporate and Other reported an adjusted operating loss of $31 million for the quarter.

  • Modest decline in GLIC's estimated RBC ratio to 289% at quarter end from 300% at year-end 2025.

Guidance & targets

CategoryTargetConfidence
Adjusted Operating Income (Closed Block)
approximately $300 million in losses
medium materiality
High
MRAP Economic Value (NPV)
approximately $1 billion
high materiality
High
ANAC Capital Returns to Genworth
around $405 million
high materiality
High
Share Repurchases
$195 million and $225 million
high materiality
High
CareScout Matches
approximately 7,500 matches
medium materiality
High
CareScout Service Revenue
$25 million
medium materiality
High
CareScout Services Investment
$50 million to $55 million
medium materiality
High
CareScout Insurance Investment
no additional investments
medium materiality
High
CareScout Quality Network (CQN) Senior Living Communities
approximately 2,000
low materiality
High
CareScout Quality Network (CQN) Home Care Locations
more than 1,000
low materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
ANAC
ANAC delivered strong performance, contributing significantly to Genworth's adjusted operating income. New insurance written decreased sequentially due to seasonal trends but increased year-over-year. The PMIERs sufficiency ratio remained strong, and the segment provided $99 million in capital returns to Genworth.
Adjusted Operating Income: $140 millionNew Insurance Written: $13 billionPrimary Insurance In Force: $272 billionEarned Premiums: $243 millionLoss Ratio: 15%PMIERs Sufficiency Ratio: 162%Genworth's Share of ANAC Book Value (including AOCI): $4.3 billion
———$140 million
Corporate and Other
The adjusted operating loss reflects continued investment in CareScout and ongoing holding company debt service. The prior quarter included a benefit from favorable tax-related items.
Adjusted Operating Loss: $31 million
———($31 million)
Closed Block
The adjusted operating loss was driven by a liability remeasurement loss related to actual variances from expected experience (AE), primarily in LTC. This was partially offset by favorable net insurance recoveries. Mortality was seasonally higher sequentially but lower than the prior year.
Adjusted Operating Loss: $32 millionLiability Remeasurement Loss (AE): $36 million pretaxNet Insurance Recoveries: $65 million pretax
———($32 million)

GNW operating KPIs by quarter

GNW operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2025 Q4 FY25This call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
CareScout matches CareScout Services
925 The team executed well in the fourth quarter, facilitating 925 matches between LTC policyholders and home care providers in our network. Source: earnings call transcript
~1,500 We facilitated approximately 1,500 matches between care seekers and providers in the first quarter reflecting strong sequential and year-over-year growth. Source: earnings call transcript
~1,450 We facilitated approximately 1,450 matches between care seekers and providers in the second quarter, bringing total matches for the first half of the year to approximately 2,950, over double the number of matches achieved in the first half of 2025. Source: earnings call transcript
—
New insurance written Enact
$14B New insurance written of $14 billion in the quarter increased versus the prior quarter and prior year. Source: earnings call transcript
$13B New insurance written of $13 billion in the quarter decreased versus the prior quarter, primarily based on seasonal trends but increased versus the prior year as a result of lower interest rates early in the quarter. Source: earnings call transcript
$15B New insurance written of $15 billion in the quarter was seasonally higher than the prior quarter, an increase versus the prior year as a result of a larger estimated market size. Source: earnings call transcript
+15.4%
Primary insurance in-force Enact
$273B Primary insurance in-force grew slightly year-over-year to $273 billion, supported by both the growth in new insurance written and continued elevated persistency. Source: earnings call transcript
$272B Primary insurance in force increased year-over-year to $272 billion supported by the growth in new insurance written and continued elevated persistency. Source: earnings call transcript
$274B Primary insurance in force increased 2% year-over-year to $274 billion, supported by new insurance written and continued elevated persistency. Source: earnings call transcript
+0.7%
PMIERs sufficiency ratio Enact
162% Enact's estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements. Source: earnings call transcript
162% In Act estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements. Source: earnings call transcript
161% Enact's estimated PMIERs sufficiency ratio remained strong at 161% or approximately $1.9 billion above requirements. Source: earnings call transcript
-1 pt

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
CareAssurancelaunch
CareAssurance worksite productlaunch
Hybrid LTC insurance productsroadmap

Deals & partnerships

senior Integration of senior living communities into CareScout Quality Network.

Integrating senior living communities from the acquisition of senior to build a more comprehensive network.

other LTC insurance carriers Leveraging CareScout Quality Network for other closed LTC blocks.

Working with other carriers managing closed LTC blocks to integrate their policyholders into the CareScout Quality Network.

select affinity groups Introducing consumers to CareScout brand and platform.

Partnering with affinity groups to extend CareScout's platform beyond Genworth.

Risks & headwinds

Macroeconomic backdrop 2026 and beyond

uneven consumer spending, potential for higher inflation and interest rates

Mitigation:Genworth is well positioned to navigate a range of market conditions, operating from a position of strength with disciplined underwriting and strong capital position, providing strong free cash flow.

Closed Block AE losses FY26

approximately $300 million for the full year 2026

Mitigation:Management emphasizes that GAAP fluctuations do not impact cash flows, economic value, or how the business is managed. Focus on MRAP and CareScout to manage long-term sustainability.

AXA litigation uncertainty 3 to 6 months after July 21-23 appeal hearing

potential recovery of approximately $750 million, but subject to appeal decision

Mitigation:Potential recoveries are not factored into capital allocation plans; if received, proceeds will be deployed in line with existing priorities (CareScout, shareholder returns, debt reduction).

GLIC RBC ratio decline Q1 FY26

RBC ratio of 289% at quarter end, down from 300% at year-end 2025

Mitigation:Target RBC is 250% or more, current ratio is well above regulatory requirements. Strategy relies on MRAP, Benefit Solutions, Live Well Age Well program, and CareScout Quality Network to bolster RBC and statutory results.

What to watch in Q2 FY26

AXA Litigation Decision

within 3 to 6 months of hearing
Current Appeal hearing scheduled for July 21-23
Target Court of Appeal decision

Why it matters

A favorable resolution could result in a significant cash recovery of approximately $750 million, impacting capital allocation.

The appeal hearing is scheduled for July 21 through 23. We expect the Court of Appeal to reach a decision within approximately 3 to 6 months of adhering.

Find out whether GNW delivers this. Inve re-checks your case every morning.

Q&A highlights

The analyst noted a modest decline in GLIC's estimated RBC ratio and asked if there's a specific level that would force or prompt capital contributions, or if there are other levers to bolster RBC without capital contributions.

Management stated their target RBC is 250% or more, and they are comfortable with the current 289% ratio, which is well above regulatory requirements. They reiterated that no capital contributions are planned and highlighted that the strategy relies on the Multiyear Rate Action Plan (MRAP), Benefit Solutions, Live Well Age Well program, and CareScout Quality Network to drive RBC and statutory results.

“Our target is to have RBC at 2.50% or more. And so we're very comfortable with where we are. Obviously, there -- the RBC did go down in the first quarter because of the statutory loss but that's where we have quite a bit of room. There's no requirement from a regulatory perspective. I mean, we're well above at almost 3x required capital, what the regulators require.”

asked by Joshua Esterov · answered by Thomas McInerney

2 min read 6 chapters

Detailed narrative

New Reporting Structure for Core Operating Earnings

Genworth has updated its presentation of core operating earnings to exclude the Closed Block of legacy insurance products. This new view aims to better align with the company's strategy and capital allocation framework, focusing on driving current and future shareholder returns through ANAC and long-term growth opportunities with CareScout.

The adjusted operating income for the Closed Block will continue to be reported separately, acknowledging its self-sustaining nature and the GAAP volatility that does not reflect its underlying economics.

CareScout Growth and Strategic Expansion

CareScout is expanding its Quality Network (CQN) across both home care and senior living communities, adding its first senior living communities in Q1 FY26. The network now covers approximately 97% of the U.S. population aged 65 and older for home care.

CareScout facilitated about 1,500 matches in the quarter, including direct-to-consumer matches, and is on track for 7,500 matches and $25 million in service revenues for FY26. The company is also scaling fee-for-service offerings and developing new products like CareAssurance and hybrid LTC insurance.

Multiyear Rate Action Plan (MRAP) Progress

The MRAP continues to be a critical lever for the self-sustainability of the Closed Block. In Q1 FY26, Genworth secured $5 million in gross incremental premium approvals, with an additional $45 million achieved in Q2. Since 2012, the program has generated approximately $34.5 billion in net present value through premium increases and benefit reductions.

The company expects FY26 premium approvals and benefit reductions to be broadly in line with 2025 levels, contributing about $1 billion of economic value.

AXA Litigation Update and Potential Recovery

The appeal hearing for the AXA litigation is scheduled for July 21-23, with a decision expected within 3 to 6 months thereafter. If the judgment is upheld and appeals are favorably resolved, Genworth anticipates recovering approximately $750 million, subject to exchange rates, with no expected tax implications.

Any proceeds from this recovery are not factored into current capital allocation plans but would be deployed towards CareScout investments, shareholder returns, and debt reduction.

Investment Portfolio and Capital Allocation

Genworth's investment portfolio is conservatively positioned with a majority in investment-grade fixed maturities. New money yields for life insurance companies are approximately 6.3% for the quarter. The alternative assets program, largely diversified private equity, targets returns of about 12%. Capital allocation priorities remain investing in CareScout, returning cash to shareholders through share repurchases (targeting $195M-$225M for FY26), and opportunistically retiring debt, with $5 million of principal debt retired in Q1 FY26.

AI and Technology Integration

Genworth is actively integrating new technology and operational capabilities, including artificial intelligence and generative AI initiatives, across the organization. These efforts, in partnership with key partners, are focused on improving efficiencies in client management, enhancing policyholder and customer service, and supporting scalable growth for CareScout. The approach emphasizes tech-enabled human-centered support throughout the aging journey.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.